Return to Trial Database

BRE03-60

A Phase II Trial of Capecitabine and Oxaliplatin (CAPOX) in Patients With Metastatic Breast Cancer: Hoosier Oncology Group BRE03-60

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial BRE03-60 being conducted in.

No data was found